We describe the case of a 69-year-old man who presented with symptoms of headache and severe vision loss due to G4 immunoglobulin (IgG4) hypertrophic pachymeningitis (HP). The patient was initially responsive to corticotherapy, but vision loss progressed when steroid therapy was first tapered. No improvement was noticed with intravenous rituximab. The patient showed clinical and radiological improvement after intrathecal rituximab, which can be an efficacious alternative treatment option.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jneuroim.2019.576997 | DOI Listing |
Publication Analysis
Top Keywords
intrathecal rituximab
8
vision loss
8
rituximab immunoglobulin
4
immunoglobulin g4-hypertrophic
4
g4-hypertrophic pachymeningitis
4
pachymeningitis describe
4
describe case
4
case 69-year-old
4
69-year-old man
4
man presented
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!